相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Incidence Density of Invasive Fungal Infections during Primary Antifungal Prophylaxis in Newly Diagnosed Acute Myeloid Leukemia Patients in a Tertiary Cancer Center, 2009 to 2011
Marisa Z. R. Gomes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Invasive fungal diseases during first induction chemotherapy affect complete remission achievement and long-term survival of patients with acute myeloid leukemia
Corrado Girmenia et al.
LEUKEMIA RESEARCH (2014)
The incidence of invasive fungal infections in neutropenic patients with acute leukemia and myelodysplastic syndromes receiving primary antifungal prophylaxis with voriconazole
Jason N. Barreto et al.
AMERICAN JOURNAL OF HEMATOLOGY (2013)
Global spread of antibiotic resistance: the example of New Delhi metallo-β-lactamase (NDM)-mediated carbapenem resistance
Alan P. Johnson et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2013)
The costs of initial treatment for patients with acute myeloid leukemia in the Netherlands
Annemieke Leunis et al.
LEUKEMIA RESEARCH (2013)
Role of minimal residual disease monitoring in acute promyelocytic leukemia treated with arsenic trioxide in frontline therapy
Ezhilarasi Chendamarai et al.
BLOOD (2012)
Acute myeloid leukemia in the real world: why population-based registries are needed
Gunnar Juliusson et al.
BLOOD (2012)
Underreporting of Myeloid Malignancies by United States Cancer Registries
Benjamin M. Craig et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2012)
Cytogenetic analysis of acute myeloid leukemia with t(8;21) from a tertiary care center in India with correlation between clinicopathologic characteristics and molecular analysis
Mayur Parihar et al.
LEUKEMIA & LYMPHOMA (2012)
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
Alison G. Freifeld et al.
CLINICAL INFECTIOUS DISEASES (2011)
Indian health: the path from crisis to progress
Richard Horton et al.
LANCET (2011)
India: Towards Universal Health Coverage 4 Health care and equity in India
Y. Balarajan et al.
LANCET (2011)
Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials
David Grimwade et al.
BLOOD (2010)
Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia
Pierre Fenaux et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Multicenter, Phase II Study of Decitabine for the First-Line Treatment of Older Patients With Acute Myeloid Leukemia
Amanda F. Cashen et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Single-Agent Arsenic Trioxide in the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia: Long-Term Follow-Up Data
Vikram Mathews et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Reducing out-of-pocket expenditures to reduce poverty: a disaggregated analysis at rural-urban and state level in India
Charu C. Garg et al.
HEALTH POLICY AND PLANNING (2009)
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Ben De Pauw et al.
CLINICAL INFECTIOUS DISEASES (2008)
Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: Results of AML-BFM 98
Ursula Creutzig et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicity
V Mathews et al.
BLOOD (2006)
Economic burden of acute myeloid leukemia: a literature review
A Redaelli et al.
CANCER TREATMENT REVIEWS (2004)
Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia
BD Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies
Y Yamamoto et al.
BLOOD (2001)
Costs of diagnosis, treatment, and follow up of patients with acute myeloid leukemia in the Netherlands
CA Uyl-de Groot et al.
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH (2001)
分享论文
